OHSU recibe $1.4 millones para programa de capacitación para desarrollar nuevo medicamento contra el cáncer
El estudiante de posgrado Jee Min Lee y Dhanir Tailor, Ph.D., en el Centro para Terapias Experimentales del Knight Cancer Institute de OHSU. (OHSU)
OHSU awarded 1.4 million for new cancer drug development training program
Ph.D. student Jee Min Lee and Dhanir Tailor, Ph.D., in the OHSU Knight Cancer Institute’s Center for Experimental Therapeutics. (OHSU)
Joshua Moreau lab at OHSU
From Left: Joshua Moreau, Ph.D., Abrar Samiea, Ph.D., George Celis, B.S., and Lauren Rodda, Ph.D., of OHSU. The team works on B cells, traditionally known for antibody production, examining how they influence immune responses and disease progression in areas like inflammation, infections, and cancer. (Courtesy of Joshua Moreau)
Joshua Moreau lab at OHSU
From Left: Joshua Moreau, Ph.D., Abrar Samiea, Ph.D., George Celis, B.S., and Lauren Rodda, Ph.D., of OHSU. The team works on B cells, traditionally known for antibody production, examining how they influence immune responses and disease progression in areas like inflammation, infections, and cancer. (Courtesy of Joshua Moreau)
Joshua Moreau lab at OHSU
Joshua Moreau, Ph.D., Abrar Samiea, Ph.D., George Celis, B.S., and Lauren Rodda, Ph.D., of OHSU, work on B cells, traditionally known for antibody production, examining how they influence immune responses and disease progression in areas like inflammation, infections, and cancer. (Courtesy of Joshua Moreau)
Review: B cells do more than produce antibodies — they also shape immune responses
Revisión: las células B hacen más que producir anticuerpos, también dan forma a las respuestas inmunes
OHSU recibe $1.4 millones para programa de capacitación para desarrollar nuevo medicamento contra el cáncer
OHSU awarded $1.4 million for new cancer drug development training program
